AM
TMO icon

AGF Management’s Thermo Fisher Scientific TMO Stock Holding History

AGF Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.5M Sell
68,779
-140,063
-67% -$67.2M 0.13% 129
2026
Q1 		$103M Buy
208,842
+72,331
+53% +$39.3M 0.46% 68
2025
Q4 		$79.1M Buy
136,511
+48,763
+56% +$27.6M 0.34% 87
2025
Q3 		$42.6M Sell
87,748
-118,109
-57% -$55M 0.19% 119
2025
Q2 		$83.5M Buy
205,857
+9,130
+5% +$3.82M 0.38% 82
2025
Q1 		$97.9M Buy
196,727
+63,201
+47% +$34.2M 0.52% 60
2024
Q4 		$69.5M Sell
133,526
-29,704
-18% -$16.3M 0.35% 89
2024
Q3 		$101M Buy
163,230
+41,007
+34% +$24.3M 0.51% 62
2024
Q2 		$67.6M Sell
122,223
-50,500
-29% -$28.9M 0.38% 87
2024
Q1 		$100M Sell
172,723
-111,573
-39% -$62.6M 0.56% 57
2023
Q4 		$151M Buy
284,296
+39,564
+16% +$19.2M 0.89% 29
2023
Q3 		$124M Buy
244,732
+44,516
+22% +$23.7M 0.88% 28
2023
Q2 		$104M Buy
200,216
+64,950
+48% +$35M 0.76% 42
2023
Q1 		$78M Sell
135,266
-49,436
-27% -$27.9M 0.53% 63
2022
Q4 		$102M Buy
+184,702
New +$97.9M 0.74% 36

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AGF Management's TMO Position: Q2 2026 in Review

AGF Management reduced its Thermo Fisher Scientific (TMO) stake by 67% in Q2 2026, selling an estimated $67.2M and leaving 68,779 shares worth $34.5M. The position accounts for 0.13% of the portfolio, ranked #129.

AGF Management first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $151M in Q4 2023. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • AGF Management held 68,779 shares of Thermo Fisher Scientific worth $34.5M as of Q2 2026.
  • AGF Management sold 140,063 Thermo Fisher Scientific shares in Q2 2026, an estimated $67.2M.
  • Thermo Fisher Scientific made up 0.13% of AGF Management's portfolio in Q2 2026, its #129 holding.
  • AGF Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • AGF Management's Thermo Fisher Scientific position peaked at $151M in Q4 2023.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.